The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index, and 1 are not checked yet.
Expression of CX 3 CR1 chemokine receptors on neurons and their role in neuronal survival
Open accessAbstract
Recent in vitro and in vivo studies have shown that the chemokine fractalkine is widely expressed in the brain and localized principally to neurons. Central nervous system expression of CX 3 CR1, the only known receptor for fractalkine, has been demonstrated exclusively on microglia and astrocytes. Thus, it has been proposed that fractalkine regulates cellular communication between neurons (that produce fractalkine) and microglia (that express its receptor). Here we show, for the first time, that hippocampal neurons also express CX 3 CR1. Receptor activation by soluble fractalkine induces activation of the protein kinase Akt, a major component of prosurvival signaling pathways, and nuclear translocation of NF-κB, a downstream effector of Akt. Fractalkine protects hippocampal neurons from the neurotoxicity induced by the HIV-1 envelope protein gp120 IIIB , an effect blocked by anti-CX 3 CR1 antibodies. Experiments with two different inhibitors of the phosphatidylinositol 3-kinase, a key enzyme in the activation of Akt, and with a phospholipid activator of Akt demonstrate that Akt activation is responsible for the neuroprotective effects of fractalkine. These data show that neuronal CX 3 CR1 receptors mediate the neurotrophic effects of fractalkine, suggesting that fractalkine and its receptor are involved in a complex network of both paracrine and autocrine interactions between neurons and glia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Meucci et al. (2000) reported that Cx3cr1is expressed in cultured neurons and promotes neuronal survival.”
From Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity (2019) · cites this paper as Meucci et al. (2000)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Wang, C.-Y., Mayo, M., Korneluk, R., Goeddel, D., & Baldwin, A. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,950
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,531
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Nidai Ozes, O., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 1,832
Flagged first, then by citations
Research works printed but not linked: 1
- C-Y Wang, M W Mayo, R G Korneluk, D V Goeddel, A S Baldwin Nature (London) 281, 1680–1683 (1998).
Cited by
Sorted by citations
Items 101–200 of 385
Fractalkine: moving from chemotaxis to neuroprotection
Ré, D. B., & Przedborski, S. (2006) · Nature Neuroscience · doi:10.1038/nn0706-859 · Cited by 93
Daoudi, M., Lavergne, E., Garin, A., Tarantino, N., Debré, P., Pincet, F., Combadière, C., & Déterre, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313457200 · Cited by 94
HIV-1 neuroimmunity in the era of antiretroviral therapy
Kraft-Terry, S. D., Stothert, A. R., Buch, S. J., & Gendelman, H. E. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.015 · Cited by 90
Trettel, F., Castro, M. A. D., & Limatola, C. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.035 · Cited by 90
Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases
Luo, P., Chu, S., Zhang, Z., Xia, C., & Chen, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.11.017 · Cited by 90
Liu, W., Jiang, L., Bian, C., Liang, Y., Xing, R., Yishakea, M., & Dong, J. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0395-9 · Cited by 92
Regulation of Adaptive Immunity by the Fractalkine Receptor during Autoimmune Inflammation
Garcia, J. A., Pino, P. A., Mizutani, M., Cardona, S. M., Charo, I. F., Ransohoff, R. M., Forsthuber, T. G., & Cardona, A. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300040 · Cited by 89
McComb, J. G., Ranganathan, M., Liu, X. H., Pilewski, J. M., Ray, P., Watkins, S. C., Choi, A. M. K., & Lee, J. S. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071034 · Cited by 86
Maggi, L., Trettel, F., Scianni, M., Bertollini, C., Eusebi, F., Fredholm, B. B., & Limatola, C. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.016 · Cited by 84
Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia
Erichsen, D. A., Lopez, A. L., Peng, H., Niemann, D., Williams, C., Bauer, M., Morgello, S., Cotter, R. L., Ryan, L. A., Ghorpade, A., et al. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00117-6 · Cited by 83
Ren, H., Yu, D., Ge, B., Cook, B., Xu, Z., & Zhang, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004509 · Cited by 84
HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis
Kaul, M. (2007) · Frontiers in bioscience · doi:10.2741/2860 · Cited by 82
Ferretti, E., Pistoia, V., & Corcione, A. (2014) · Mediators of Inflammation · doi:10.1155/2014/480941 · Cited by 89
Shen, F., Zhang, Y., Jernigan, D. L., Feng, X., Yan, J., Garcia, F. U., Meucci, O., Salvino, J. M., & Fatatis, A. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0013 · Cited by 85
Self-citationFractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model
Wang, K., Peng, B., & Lin, B. (2014) · Glia · doi:10.1002/glia.22715 · Cited by 82
Chamera, K., Trojan, E., Szuster-Głuszczak, M., & Basta‐Kaim, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191113101629 · Cited by 82
Nosheny, R. L., Bachis, A., Acquas, E., & Mocchetti, I. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03764.x · Cited by 81
Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices
Bertollini, C., Ragozzino, D., Gross, C. T., Limatola, C., & Eusebi, F. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.05.027 · Cited by 82
Microglia as Therapeutic Target for Radiation-Induced Brain Injury
Liu, Q., Yan, H., Duan, M., Yang, Q., Ren, B., & Tang, F. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158286 · Cited by 84
Zhang, M., Xu, G., Liu, W. D., Ni, Y., & Zhou, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035446 · Cited by 80
Sato, E., Shick, H. E., Ransohoff, R. M., & Hirose, K. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21583 · Cited by 80
Altered Expression of CX3CL1 in Patients with Epilepsy and in a Rat Model
Xu, Y., Zeng, K., Han, Y., Wang, L., Chen, D., Xi, Z., Wang, H., Wang, X., & Chen, G. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.024 · Cited by 77
Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD
Chen, H., Kankel, M. W., Su, S. C., Han, S., & Ofengeim, D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0060-4 · Cited by 74
Kalkonde, Y. V., MORGAN, W. W., Sigala, J. A., Maffi, S. K., Condello, C., Kuziel, W. A., Ahuja, S. S., & Ahuja, S. K. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.041 · Cited by 75
Microglia dynamics in sleep/wake states and in response to sleep loss
Deurveilher, S., Golovin, T., Hall, S., & Semba, K. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104944 · Cited by 75
Involvement of chemokines in pain
Boddeke, E. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01311-5 · Cited by 74
The role of chemokines and their receptors in ocular disease
Wallace, G. R., Curnow, J., Wloka, K., Salmon, M., & Murray, P. I. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.04.004 · Cited by 73
The neuropathogenesis of HIV-1 infection
Zink, W. E., Zheng, J., Persidsky, Y., Poluektova, L. Y., & Gendelman, H. E. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(99)00152-2 · Cited by 72
Involvement of TRPC Channels in CCL2-Mediated Neuroprotection against Tat Toxicity
Yao, H., Peng, F., Dhillon, N. K., Callen, S. E., Bokhari, S. M., Stehno‐Bittel, L., Ahmad, S. O., Wang, J. Q., & Buch, S. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2781-08.2009 · Cited by 72
Yuan, N. Y., & Kaul, M. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09868-9 · Cited by 68
Pattarini, R., Smeyne, R. J., & Morgan, J. I. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.030 · Cited by 70
Heinisch, S., Palma, J. D., & Kirby, L. G. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.10.020 · Cited by 68
HIV-1 gp120 and Drugs of Abuse: Interactions in the Central Nervous System
Silverstein, P. S., Shah, A. B., Weemhoff, J. L., Kumar, S., Singh, D. P., & Kumar, A. (2012) · Current HIV Research · doi:10.2174/157016212802138724 · Cited by 67
The Chemokine Receptor CXCR4 Regulates Cell-Cycle Proteins in Neurons
Khan, M. Z., Brandimarti, R., Musser, B. J., Resue, D. M., Fatatis, A., & Meucci, O. (2003) · Journal of NeuroVirology · doi:10.1080/13550280390201010 · Cited by 68
Self-citationNeuromodulation of Glial Function During Neurodegeneration
Stevenson, R., Samokhina, E., Rossetti, I., Morley, J. W., & Buskila, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00278 · Cited by 72
NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury
Cook, D. R., Gleichman, A. J., Cross, S. A., Doshi, S., Ho, W., Jordan‐Sciutto, K. L., Lynch, D. R., & Kolson, D. L. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07383.x · Cited by 67
CX3CL1/CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection
Chen, P., Zhao, W., Guo, Y., Xu, J., & Yin, M. (2016) · BioMed Research International · doi:10.1155/2016/8090918 · Cited by 67
Molecular mechanisms of HIV-1 associated neurodegeneration
Özdener, M. H. (2005) · Journal of Biosciences · doi:10.1007/bf02703676 · Cited by 64
Angelopoulou, E., Paudel, Y. N., Shaikh, M. F., & Piperi, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104930 · Cited by 65
Expression of functional chemokine receptors by rat cerebellar neurons
Gillard, S. E., Lü, M., Mastracci, R. M., & Miller, R. J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00005-x · Cited by 64
Self-citationNeuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.
Gemma, C., Bachstetter, A. D., & Bickford, P. C. (2010) · Europe PMC (PubMed Central) · Cited by 62
The pericyte secretome: Potential impact on regeneration
Gaceb, A., Barbariga, M., Özen, Í., & Paul, G. (2018) · Biochimie · doi:10.1016/j.biochi.2018.04.015 · Cited by 65
Yi, H., Bai, Y., Zhu, X., Lin, L., Zhao, L., Wu, X., Buch, S. J., Wang, L., Chao, J., & Yao, H. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9553-1 · Cited by 64
Ragozzino, D. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290100932 · Cited by 62
Modulation of neuronal CXCR4 by the μ-opioid agonist DAMGO
Patel, J. P., Sengupta, R., Bardi, G., Khan, M. Z., Mullen-Przeworski, A., & Meucci, O. (2006) · Journal of NeuroVirology · doi:10.1080/13550280601064798 · Cited by 61
Self-citationInteractions between Chemokines
Cook, A., Hippensteel, R., Shimizu, S., Nicolai, J., Fatatis, A., & Meucci, O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035477 · Cited by 62
Self-citationDeiva, K., Geeraerts, T., Salim, H., Leclerc, P., Héry, C., Hugel, B., Freyssinet, J., & Tardieu, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03800.x · Cited by 61
Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
Zuena, A. R., Casolini, P., Lattanzi, R., & Maftei, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00622 · Cited by 61
van de Bovenkamp, M., Nottet, H. S. L. M., & Pereira, C. F. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01029.x · Cited by 60
Heinisch, S., & Kirby, L. G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.075 · Cited by 60
Lv, B., Huo, F., Zhu, Z., Xu, Z., Xiaojie, D., Chen, T., Zhang, T., & Yang, X. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1905-1 · Cited by 59
Membrane‐bound form of fractalkine induces IFN‐γ production by NK cells
Yoneda, O., Imai, T., Nishimura, M., Miyaji, M., Mimori, T., Okazaki, T., Domae, N., Fujimoto, H., Minami, Y., Kono, T., et al. (2002) · European Journal of Immunology · doi:10.1002/immu.200390007 · Cited by 61
Chemokine Receptors and Neural Function
Cho, C., & Miller, R. J. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290101003 · Cited by 59
Self-citationIschemia-induced Neuronal Cell Death Is Mediated by Chemokine Receptor CX3CR1
Wang, J., Gan, Y., Han, P., Yin, J., Liu, Q., Ghanian, S., Gao, F., Gong, G., & Tang, Z. (2018) · Scientific Reports · doi:10.1038/s41598-017-18774-0 · Cited by 58
Neuropathogenesis of central nervous system HIV-1 infection
Kolson, D. L. (2002) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(02)00009-4 · Cited by 57
Gröne, H., Cohen, C. D., Diaeresis]ne, E. G., Schmidt, C. S., Kretzler, M., Diaeresis]ndorff, D. S., & Nelson, P. J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134957 · Cited by 57
Minagar, A., Commins, D., Alexander, J., Hoque, R., Chiappelli, F., Singer, E. J., Nikbin, B., & Shapshak, P. (2008) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256266 · Cited by 56
Khan, M. Z., Brandimarti, R., Patel, J. P., Huynh, N. V., Wang, J., Huang, Z., Fatatis, A., & Meucci, O. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2004.20.1063 · Cited by 56
Self-citationHIV‐1 infection and neurocognitive impairment in the current era
Tamarit, M. D. P., Álvarez, S., & Muñoz‐Fernández, M. Á. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.711 · Cited by 56
Yeo, S.-I., Kim, J.-E., Ryu, H. J., Seo, C. H., Lee, B. C., Choi, I.-G., Kim, D.-S., & Kang, T.-C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.03.005 · Cited by 55
Bachis, A., & Mocchetti, I. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10826 · Cited by 55
Lauro, C., Catalano, M., Trettel, F., Mainiero, F., Ciotti, M. T., Eusebi, F., & Limatola, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7599 · Cited by 54
Vitale, S., Schmid‐Alliana, A., Breuil, V., Pomeranz, M., Millet, M.-A., Rossi, B., & Schmid‐Antomarchi, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.585 · Cited by 54
Rancan, M., Bye, N., Otto, V. I., Trentz, O., Kossmann, T., Frentzel, S., & Morganti-Kossmann, M. C. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000133470.91843.72 · Cited by 54
Higher Plasma Fractalkine Is Associated With Better 6-Month Outcome From Ischemic Stroke
Donohue, M. M., Cain, K., Zierath, D., Shibata, D., Tanzi, P. M., & Becker, K. J. (2012) · Stroke · doi:10.1161/strokeaha.112.657411 · Cited by 53
HIV associated neurocognitive disorders
Zhou, L., & Saksena, N. K. (2013) · Infectious Disease Reports · doi:10.4081/idr.2013.s1.e8 · Cited by 52
A polymorphism in CCR1/CCR3 is associated with narcolepsy
Toyoda, H., Miyagawa, T., Koike, A., Kanbayashi, T., Imanishi, A., Sagawa, Y., Kotorii, N., Kotorii, T., Hashizume, Y., Ogi, K., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.05.003 · Cited by 53
Quinones, M. P., Kalkonde, Y. V., Estrada, C. A., Jiménez, F., Ramirez, R. A., Mahimainathan, L., Mummidi, S., Choudhury, G. G., Martinez, H. G., Adams, L. M., et al. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.08.017 · Cited by 54
Kansra, V. V., Groves, C., Gutierrez‐Ramos, J. C., & Polakiewicz, R. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009374200 · Cited by 53
Molecular Determinants of Receptor Binding and Signaling by the CX3C Chemokine Fractalkine
Mizoue, L. S., Sullivan, S. K., King, D., Kledal, T. N., Schwartz, T. W., Bacon, K. B., & Handel, T. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101348200 · Cited by 54
Xu, J., Long, L., Tang, Y. C., Zhang, J. T., Hu, H., & Tang, F. R. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01022.x · Cited by 51
Leonardo, H. T. (2005) · Frontiers in bioscience · doi:10.2741/1562 · Cited by 52
Chemokine receptors in the brain: their role in HIV infection and pathogenesis
Martín‐García, J., Kolson, D. L., & González‐Scarano, F. (2002) · AIDS · doi:10.1097/00002030-200209060-00003 · Cited by 51
Zhang, B., Zou, J., Han, L., Beeler, B., Friedman, J. L., Griffin, E., Piao, Y., Rensing, N. R., & Wong, M. (2018) · Epilepsia · doi:10.1111/epi.14526 · Cited by 50
Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease
Camacho-Hernández, N. P., & Peña‐Ortega, F. (2023) · Neural Plasticity · doi:10.1155/2023/4637073 · Cited by 52
Fujita, M., Takada, Y. K., & Takada, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096372 · Cited by 46
Regulation of neuronal P53 activity by CXCR4
Khan, M. Z., Shimizu, S., Patel, J. P., Nelson, A., Le, M.-T., Mullen-Przeworski, A., Brandimarti, R., Fatatis, A., & Meucci, O. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.05.007 · Cited by 48
Self-citationChemokine receptors in the brain: A developing story
Tran, P. B., & Miller, R. J. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10546 · Cited by 47
Self-citationSingh, K. K., & Spector, S. A. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819dca03 · Cited by 46
Liu, J. X., Cao, X., Tang, Y. C., Liu, Y., & Tang, F. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04272.x · Cited by 46
Chen, X., Geller, E. B., Rogers, T. J., & Adler, M. W. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.066 · Cited by 46
Piccinin, S., Angelantonio, S. D., Piccioni, A., Volpini, R., Cristalli, G., Fredholm, B. B., Limatola, C., Eusebi, F., & Ragozzino, D. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.012 · Cited by 45
Walter, H. L., van der Maten, G., Antunes, A. R. P., Wieloch, T. W., & Ruscher, K. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0232-1 · Cited by 47
Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND
Sánchez, A. B., & Kaul, M. (2017) · Brain Sciences · doi:10.3390/brainsci7030025 · Cited by 45
Sui, Z., Sniderhan, L. F., Fan, S., Kaźmierczak, K., Reisinger, E., Kovács, A., Potash, M. J., Dewhurst, S., Gelbard, H. A., & Maggirwar, S. B. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04813.x · Cited by 44
Developmental changes in the expression of chemokine receptor CCR1 in the rat cerebellum
Cowell, R. M., & Silverstein, F. S. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10554 · Cited by 44
Kōyama, Y., Kotani, M., Sawamura, T., Kuribayashi, M., Konishi, R., & Michinaga, S. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-51 · Cited by 44
Thomas, D. M., Francescutti, D. M., & Kuhn, D. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05421.x · Cited by 43
Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenaline
González‐Prieto, M., Gutiérrez, I. L., García‐Bueno, B., Caso, J. R., Leza, J. C., Ortega‐Hernández, A., Gómez‐Garré, D., & Madrigal, J. L. M. (2020) · Glia · doi:10.1002/glia.23885 · Cited by 42
An emerging role for microglia in stress‐effects on memory
Sanguino‐Gómez, J., Buurstede, J. C., Abiega, O., Fitzsimons, C. P., Lucassen, P. J., Eggen, B. J. L., Lesuis, S. L., Meijer, O. C., & Krugers, H. J. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15188 · Cited by 43
Intra‐neural administration of fractalkine attenuates neuropathic pain‐related behaviour
Holmes, F. E., Arnott, N., Vanderplank, P. A., Kerr, N. C. H., Longbrake, E. E., Popovich, P. G., Imai, T., Combadière, C., Murphy, P. M., & Wynick, D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05419.x · Cited by 41
Nevo, I., Sagi‐Assif, O., Meshel, T., Ben‐Baruch, A., Jöhrer, K., Greil, R., Trejo, L., Kharenko, O., Feinmesser, M., Yron, I., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.07.029 · Cited by 45
El-Derany, M. O., & Noureldein, M. H. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02384-9 · Cited by 41
Wei, L., Cao, S., Yu, W., Liu, Y., & Wang, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3645 · Cited by 42
Suzuki, M., El‐Hage, N., Zou, S., Hahn, Y.-K., Sorrell, M. E., Sturgill, J., Conrad, D. H., Knapp, P. E., & Hauser, K. F. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-78 · Cited by 38
Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
Lu, X. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220629140540 · Cited by 41
Blauth, K., Zhang, X., Chopra, M., Rogan, S. C., & Markovic‐Plese, S. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.01.001 · Cited by 40
Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure
Koziolek, M. J., Muller, G. A., Zapf, A., Patschan, D., Schmid, H., Cohen, C. D., Koschnick, S., Vasko, R., Bramlage, C. P., & Strutz, F. M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp602 · Cited by 39
Zhang, D., Stumpo, D. J., Graves, J. P., DeGraff, L. M., Grissom, S. F., Collins, J. B., Li, L., Zeldin, D. C., & Blackshear, P. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03930.x · Cited by 37
Ostuni, M. A., Guellec, J., Hermand, P., Durand-Smet, P., Combadière, C., Pincet, F., & Déterre, P. (2014) · Biology Open · doi:10.1242/bio.20149845 · Cited by 40
Metadata
- Authors
- Meucci, O., Fatatis, A., Simen, A. A., & Miller, R. J.
- Affiliations
- University of Chicago (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-06-27
- Volume
- 97
- Issue
- 14
- Pages
- 8075-8080
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC16672
- OpenAlex
- W2071832924
- Cited by
- 385
- References
- 40
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 12 · 2023: 13 · 2022: 10 · 2021: 14 · 2020: 12 · 2019: 14 · 2018: 10 · 2017: 3 · 2016: 13 · 2015: 10 · 2014: 19 · 2013: 12 · 2012: 16
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Update notices
- correction (2001-12-18)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01ns033826-05, NS33826, NS21442)
- U.S. Public Health Service (MC40165)
- National Institute on Drug Abuse (R01DA002121, DA-02121)
- National Institute of Neurological Disorders and Stroke (P01NS021442, NS-33826)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD007009)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- fractalkine, CX3CR1, hippocampal neurons, neuronal survival, neuroprotection, Akt signaling, NF-κB nuclear translocation, phosphatidylinositol 3-kinase, neurotrophic effects, neuron-glia interactions, chemokine receptors
- MeSH terms
- NF-KappaB Inhibitor alpha, CX3C Chemokine Receptor 1, Animals, Astrocytes, Cell Survival, DNA-Binding Proteins, Hippocampus, Membrane Proteins, Neurons, Phosphatidylinositols, Proto-Oncogene Proteins, Recombinant Proteins, Signal Transduction, Receptors, HIV, NF-kappa B, Protein Serine-Threonine Kinases, Receptors, Cytokine, Chemokines, CXC, Phosphatidylinositol 3-Kinases, Chemokines, CX3C, I-kappa B Proteins, Culture Techniques, Proto-Oncogene Proteins c-akt, Rats, Chemokine CX3CL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review